Clinical trial · Interventional
IT-system Development for Reaching Cervix Cancer Screening Non-attenders
IT-system Development for Individualization of Cervix Cancer Screening and Implementation of New Strategies to Reach Non-attenders
NCT02750124CI-TRIAL-00047476unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The main purpose is to develop and test an IT-infrastructure to provide more individualized ways of inviting and reaching women who have not participated, despite having been invited with annual reminders, in cervix cancer screening program during a ten year period.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
| Human Papillomavirus DNA Tests | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cobas PCR Female swab sample Packet | Device | — | UNRESOLVED |
| Routine practice | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- type
- ACTIVE_COMPARATOR
- label
- HPV self sampling test sent
- description
- A Cobas PCR (polymerase chain reaction) Female swab sample Packet will be sent directly to women with a study invitation letter and instructions. Response rate will be measured.
- interventionNames
- Device: Cobas PCR Female swab sample Packet
- type
- ACTIVE_COMPARATOR
- label
- HPV self sampling test ordered
- description
- An invitation to order a Cobas PCR Female swab sample Packet through an online application will be sent. Response rates will be measured.
- interventionNames
- Device: Cobas PCR Female swab sample Packet
- type
- ACTIVE_COMPARATOR
- label
- Nurse navigator contact
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 33 Years
- Maximum age
- 60 Years
Show eligibility criteria text
Inclusion Criteria: * Non-participants in cervical cancer screening during a 10 year period Exclusion Criteria: * Active refusers
References
Publications (2)
- RESULTElfstrom KM, Sundstrom K, Andersson S, Bzhalava Z, Carlsten Thor A, Gzoul Z, Ohman D, Lamin H, Eklund C, Dillner J, Tornberg S. Increasing participation in cervical screening by targeting long-term nonattenders: Randomized health services study. Int J Cancer. 2019 Dec 1;145(11):3033-3039. doi: 10.1002/ijc.32374. Epub 2019 May 10. PMID 31032904
- DERIVEDAndersson S, Belkic K, Mints M, Ostensson E. Acceptance of Self-Sampling Among Long-Term Cervical Screening Non-Attenders with HPV-Positive Results: Promising Opportunity for Specific Cancer Education. J Cancer Educ. 2021 Feb;36(1):126-133. doi: 10.1007/s13187-019-01608-0. PMID 31522376